# A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions

> **NCT02201511** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 3 mg PF-06412562 MR tablets_Fasted
- **DRUG:** 2 x 15 mg PF-06412562 MR tablets_Fasted
- **DRUG:** 2 x 15 mg PF-06412562 MR tablets_Fed
- **DRUG:** 10 mg PF-06412562 IR tablets

## Key facts

- **NCT ID:** NCT02201511
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201511, "A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02201511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*